BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

6:36 PM
 | 
Feb 28, 2008
 |  BC Extra  |  Clinical News

Novartis ends RCC trial early after meeting endpoint

Novartis (NYSE:NVS; SWX:NOVN) said an IDMC recommended stopping the Phase III RECORD-1 trial to treat metastatic renal...

Read the full 70 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >